GENFIT (EPA:GNFT) | WebDisclosure

BRIEF

published on 05/22/2025 at 22:15, 10 days 15 hours ago

GENFIT: First Quarter 2025 Financial Results

Treasury Royalties GENFIT Iqirvo® Clinical Phase
BRIEF

published on 05/22/2025 at 22:15, 10 days 15 hours ago

GENFIT : Résultats financiers du premier trimestre 2025

Trésorerie Royalties GENFIT Iqirvo® Phase Clinique
PRESS RELEASE

published on 05/22/2025 at 22:10, 10 days 15 hours ago

GENFIT Reports First Quarter 2025 Financial Information
GENFIT reports Q1 2025 financial information showing cash position growth and revenue increase. Details on Royalty Financing agreement, research efforts, and corporate governance update included

Financial Information Revenue Cash Position GENFIT Q1 2025
PRESS RELEASE

published on 05/22/2025 at 22:10, 10 days 15 hours ago

GENFIT : Information financière du premier trimestre 2025
GENFIT annonce sa position de trésorerie au 31 mars 2025 et son chiffre d’affaires pour le premier trimestre 2025. L'entreprise évolue dans le domaine des maladies rares du foie

Chiffre D'affaires Trésorerie Maladies Rares GENFIT Foie
BRIEF

published on 05/20/2025 at 22:15, 12 days 15 hours ago

GENFIT reçoit 26,5 millions d'euros suite à une étape clé en Italie

Italie Cholangite Biliaire Primitive GENFIT Iqirvo® Versament D'étape
BRIEF

published on 05/20/2025 at 22:15, 12 days 15 hours ago

GENFIT receives €26.5 million following a key milestone in Italy

Italy Primary Biliary Cholangitis GENFIT Milestone Payment Iqirvo®
PRESS RELEASE

published on 05/20/2025 at 22:10, 12 days 15 hours ago

GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
GENFIT to receive a €26.5 million milestone payment for pricing approval of Ipsen's Iqirvo® in Italy. This unlocks a new phase for pipeline progress in liver diseases

Approval GENFIT Milestone Payment Ipsen Iqirvo®
PRESS RELEASE

published on 05/20/2025 at 22:10, 12 days 15 hours ago

GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie
GENFIT va recevoir un paiement d'étape de 26,5 millions d'euros suite à l'approbation d'Iqirvo® par Ipsen en Italie pour le traitement de la cholangite biliaire primitive

Approbation GENFIT Paiement D'étape Ipsen Iqirvo®
BRIEF

published on 05/14/2025 at 22:15, 18 days 15 hours ago

GENFIT Releases 2025 Extra-Financial Performance Report for 2024

Sustainability ESG Biopharmaceutical Corporate Responsibility GENFIT
BRIEF

published on 05/14/2025 at 22:15, 18 days 15 hours ago

GENFIT publie son rapport de performance extra-financière 2025 pour 2024

ESG Biopharmaceutique Durabilité Responsabilité D'entreprise GENFIT

1 2 ... 9

Published on 06/02/2025 at 13:30, just now

Orogen Royalties Announces Profitable Q1-2025 Results and Expansion of High-Grade Gold and Silver Mineralization at Navidad
Published on 06/02/2025 at 13:00, 30 minutes ago

Athena Gold Provides Option on Excelsior Springs and Kicks off 2025 Field Season at Laird Lake
Published on 06/02/2025 at 13:00, 30 minutes ago

Grid Metals Corp. To Participate in THE Mining Investment Event; Engages Leading Cesium Industry Expert
Published on 06/02/2025 at 13:00, 30 minutes ago

Lahontan Mobilizes Drill Rig to Santa Fe
Published on 06/02/2025 at 13:00, 30 minutes ago

Snipp Interactive Reports Q1 2025 Financial Results - Company to Hold Investor Conference Call on June 3, 2025

View all ACCESSWIRE

Published on 06/02/2025 at 13:01, 29 minutes ago

Nebius Group announces private placement of $1 billion in aggregate principal amount of convertible notes
Published on 06/02/2025 at 13:00, 30 minutes ago

Resolutions Of Annual General Meeting of Shareholders of Eleving Group held on 2 June 2025
Published on 06/02/2025 at 12:50, 40 minutes ago

Stakeholders Commend Zimbabwe’s Historic Compensation for Former Farm Owners, Urge Continued Support for the Structured Dialogue Process
Published on 06/02/2025 at 12:48, 42 minutes ago

Issue of Equity
Published on 06/02/2025 at 12:30, 1 hour ago

Immunic to Participate in Investor, Scientific and Industry Conferences in June

View all EQS

Published on 05/30/2025 at 22:00, 2 days 15 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 2 days 15 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 2 days 19 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 4 days 14 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 4 days 14 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News